home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

12 rows where docket_id = "FDA-1977-N-0023" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 3

  • Supporting & Related Material 10
  • Other 1
  • Proposed Rule 1

posted_year 2

  • 2003 10
  • 1996 2

agency_id 1

  • FDA 12
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1977-N-0023-0005 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Reference 5 : Verheugt, F. W. et al., "Effects of Early Intervention with Low Dose Aspirin (100 mg) on Infarct Size, Reinfarction and Mortality in Anterior Wall Acute Myocardial Infarction," American Journal of Cardiology, 66:267-270, 1990 re: Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-12T17:08:47Z   0 0 09000064805da1f0
FDA-1977-N-0023-0008 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Reference 9 : Husted, S. E. et al., "Acetylsalicylic Acid 100 mg and 1,000 mg Daily in Acute Myocardial Infarction Suspects: A Placebo-Controlled Trial," Journal of Internal Medicine, 226:303-310, 1989 re: Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-12T17:34:26Z   0 0 09000064805da1f3
FDA-1977-N-0023-0006 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Reference 6 : Hays, L. J. et al., "Short-term Infarct Vessel Patency with Aspirin and Dipyridamole Started 24 to 36 Hours after Intravenous Streptokinase," American Heart Journal, 115:717-721, 1988. re: Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-12T17:15:00Z   0 0 09000064805da1f1
FDA-1977-N-0023-0010 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-13T19:04:25Z   0 0 09000064805da1f5
FDA-1977-N-0023-0009 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Tab 1.2 - Correspondence re: Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-12T18:52:35Z   0 0 09000064805da1f4
FDA-1977-N-0023-0012 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Reference 7 : ISIS Pilot Study Investigators, "Randomized Factorial Trial of High-Dose Intravenous Streptokinase, of Oral Aspirin and of Intravenous Heparin in Acute Myocardial Infarction," European Heart Journal 8:634-642, 1987 re: Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-12T17:21:23Z   0 0 09000064805da1f7
FDA-1977-N-0023-0004 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Reference 4 : RISC Group, "Risk of Myocardial Infarction and Death During Treatment with Low Dose Aspirin and Intravenous Heparin in Men with Unstable Coronary Artery Disease," Lancet, 336:827-830, 1990 re: Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-13T19:06:47Z   0 0 09000064805da1ef
FDA-1977-N-0023-0003 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Reference 3 : ISIS-2 (Second International Study of Infarct Survival) Collaborative Group, "Randomized Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17,187 Cases of Suspected Acute Myocardial Infarction: ISIS-2," Lancet, 2:349-360, 1988. re: Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-13T19:06:14Z   0 0 09000064805da1ee
FDA-1977-N-0023-0011 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Tab 1.1 - References (3 through 9) re: Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-13T19:05:34Z   0 0 09000064805da1f6
FDA-1977-N-0023-0007 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Reference 8 : Elwood, P. C., and W. 0. Williams, "A Randomized Controlled Trial of Aspirin in the Prevention of Early Mortality in Myocardial Infarction," Journal of the Royal College of General Practitioners, 29:413-416, 1979. re: Background Material from FDA Supporting & Related Material Background Material 2003-06-17T04:00:00Z 2003 6     2019-02-12T17:30:23Z   0 0 09000064805da1f2
FDA-1977-N-0023-0002 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Internal Memorandum from Valerie J. Miguele (HFD-560) to FDA DDM (HFA-305) June 17, 1996 Other Memorandum 1996-07-02T04:00:00Z 1996 7     2019-02-13T14:22:59Z   0 0 09000064805da1b5
FDA-1977-N-0023-0001 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment to the Tentative Final Monograph Proposed Rule Notice of Proposed Rulemaking (NPRM) 1996-06-25T04:00:00Z 1996 6 1996-06-25T04:00:00Z 1996-09-12T03:59:59Z 2019-03-23T23:59:37Z 96-14894 0 0 09000064805da1b4

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
Powered by Datasette · Queries took 36.986ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API